Search bioRxiv⌕ Search

Biology subjects

Huskova, A.

Publications and source records attributed to Huskova, A..

3 recordsLinked to original sources

Catalytic and Structural Insights into Neil3-Dependent Unhooking of Endogenous Abasic DNA Crosslink

Abasic (Ap) sites arise frequently in genomic DNA and can form interstrand crosslinks (Ap-ICLs) that block DNA replication and threaten genome stability. The DNA glycosylase NEIL3 is required for replication-coupled repair of Ap-ICLs, yet its catalytic mechanism has remained unclear, as biochemical studies report lyase-dependent strand cleavage whereas cellular systems indicate incision-free unhooking. Here, we show that the catalytic outcome of NEIL3 is determined by the N-terminal processing of its NEI domain. Using biochemically and structurally defined NEI variants, we demonstrate that a native-like processed form (V2M), in which valine 2 is replaced by an initiating methionine, efficiently unhooks Ap-ICLs by releasing the crosslinked strand without generating toxic DNA strand breaks, and without {beta}- or {delta}-elimination. In contrast, an unprocessed form (M1) exhibits elevated Ap-lyase activity and generates strand breaks. Time-resolved Schiff-base trapping in the presence of a reducing agent reveals distinct high-molecular-weight intermediates during Ap-ICL unhooking. A crystal structure of NEIL3 bound to native-like substrate in form of a single-stranded DNA identifies features underlying its preference for fork-like substrates. Together, these findings reconcile previously conflicting models of NEIL3 function and define a mechanistic framework for replication-coupled repair of endogenous crosslinks, Ap-ICL, preserving fork integrity.

biochemistry↗

Mechanistic Insights into Alcohol-Induced DNA Crosslink Repair by the Fanconi Anemia Nuclease Slx4-Xpf-Ercc1

During cell division, DNA replication stalls upon alcohol-derived interstrand crosslink, employing DNA repair pathways. Acetaldehyde, a toxic metabolite of alcohol, can induce DNA crosslinks between complementary DNA strands, causing significant genomic instability. The repair of acetaldehyde DNA crosslinks (AA-ICLs) is vital for maintaining genome integrity and preventing mutagenic events. The Fanconi anemia (FA) repair pathways involvement in fixing the AA-ICLs is crucial, ensuring cellular homeostasis and safeguarding genomic stability. Dysregulation of the FA pathway has been linked to Fanconi anemia, a rare genetic disorder characterized by hypersensitivity to DNA-damaging agents, including acetaldehyde. However, the precise mechanism of the repair and incision of AA-ICLs is unknown. Here, we demonstrate the role of the FA pathway nuclease SLX4-XPF-ERCC1 (SXE) in the repair of AA-ICL. We have generated site-specific AA-ICL within the replication fork, and we found SXE to excise the crosslink from the replication fork, bringing evidence of its role in the repair of alcohol-induced DNA lesions. This nuclease complex performs two precise incisions around the lesion. We also demonstrate that the SXE nuclease excises an abasic site interstrand crosslink in a similar manner. Given the evidence in conjunction with previous repair studies that have been conducted, our work suggests that SXE is a versatile nuclease complex.

biochemistry↗

High-throughput fluorescent assay for inhibitor screening of proteases from RNA viruses

Spanish flu and other influenza outbreaks, the recent Zika epidemics, and the ongoing COVID-19 pandemic are the most profound examples of severe widespread diseases that are caused by RNA viruses. Perhaps less well known yet dangerous RNA viruses cause deadly diseases such as polio, Ebola, measles, rubella, yellow fever, dengue fever and many others. To combat a particular viral disease by diminishing its spread and number of fatal cases, effective vaccines and antivirals are indispensable. Therefore, quick access to the means of discovery of new treatments for any epidemic outbreak is of great interest and in vitro biochemical assays are the basis of drug discovery. The recent outbreak of the coronavirus pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) demands an affordable and reliable assay for testing antivirals. Here, we developed a quick and inexpensive high-throughput fluorescent assay to test inhibitors of viral proteases. Accordingly, we employed this assay to sample inhibitors for papain-like protease from SARS-CoV-2. In addition, we validated this assay for screening inhibitors of flaviviral protease from the tick-borne encephalitis virus to emphasize a broad range of applications of our approach. This fluorescent high-throughput assay is based on fluorescent energy transfer (FRET) between two distinct fluorescent proteins (eGFP and mCherry) connected via a substrate polypeptide. When the substrate is cleaved, FRET is abolished and the change in fluorescence corresponds to reaction progress. Our data show that this assay can be used for testing the inhibitors in the 96 or 384 well plates format with robust and reproducible outcomes.

biochemistry↗